Ovarian Clear Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Ovarian Clear Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100 [Phase 1, Phase 2]
A Phase 1/2 trial is evaluating the safety and efficacy of dostarlimab plus LB-100 targeting PP2A in ovarian clear cell carcinoma, and it is…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Efficacy and Safety of Sacituzumab in Patients With OCCC After Immunotherapy Progression
A clinical trial update evaluating the efficacy and safety of sacituzumab govitecan in patients with ovarian clear cell carcinoma after prog…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer [Phase 2]
This is a Phase 2 clinical trial evaluating tazemetostat for recurrent ovarian or endometrial cancers; the study is currently not recruiting…
-
CLINICAL_TRIALS trial_result · 2024-08-13Clinical Trial Update: Sintilimab Plus Bevacizumab in Recurrent/Persistent Ovarian Clear Cell Carcinoma [Phase 2]
Completed Phase 2 study of sintilimab plus bevacizumab in recurrent/persistent ovarian clear cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: Zimberelimab Plus Metformin for Recurrent Ovarian Clear Cell Carcinoma [Phase 1, Phase 2]
A clinical trial evaluating zimberelimab in combination with metformin for recurrent ovarian clear cell carcinoma is underway (Phase 1/2).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: A Study of ENMD-2076 in Ovarian Clear Cell Cancers [Phase 2]
Phase 2 trial studying ENMD-2076 in ovarian clear cell carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Sunitinib® in Patients With Recurrent Ovarian Clear Cell Carcinoma [Phase 2]
A Phase 2 clinical trial update for sunitinib in patients with recurrent ovarian clear cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: A Multicentre Phase II Trial of Durvalumab Versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinomas [Phase 2]
Multicenter Phase II randomized study comparing durvalumab to physician's choice chemotherapy in recurrent ovarian clear cell carcinoma; cur…
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer [Phase 2]
A Phase 2 trial evaluating a combination chemotherapy regimen with peripheral stem cell transplantation for stage III ovarian cancer has bee…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer [Phase 2]
Phase 2 trial evaluating Temsirolimus, Carboplatin, and Paclitaxel as first-line therapy for newly diagnosed stage III-IV clear cell ovarian…
-
CLINICAL_TRIALS trial_result · 2016-08-15Clinical Trial Update: Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium [Phase 2]
A Phase 2 trial is comparing nintedanib against chemotherapy in patients with recurrent ovarian clear cell carcinoma or recurrent endometria…